Mesoblast Limited
MESONASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $1.60B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $11.89$21.50
- Volume (live)
- -
- Avg. volume (3M)
- 260.29K
Mesoblast (MESO) Stock Price & Financial Analysis
Mesoblast Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $12.33 - $12.48 |
|---|---|
| 52-Week High | $21.50 |
| 52-Week Low | $11.89 |
| Open | $12.38 |
| Volume (last close) | 107.35K |
| Average Volume (3M) | 260.29K |
| Revenue (TTM) | 120.79M |
|---|---|
| Net Income (TTM) | -57.50M |
| Free Cash Flow (TTM) | -42.36M |
| EPS (TTM) | −$0.44 |
| Profit Margin | -47.60% |
| Operating Margin | -97.78% |
| Return on Equity (ROE) | -10.12% |
| Debt to Equity | 0.22 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.60B |
|---|---|
| Shares Outstanding | 129.49M |
| Price to Sales (P/S) | 13.28 |
| Price to Book (P/B) | 2.82 |
| EV/EBITDA | -37.88 |
| 50-Day MA | $15.46 |
|---|---|
| 200-Day MA | $15.63 |
| 1-Year Change | −26.61% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Mesoblast at a Glance
As of the Oct 26, 2026 close, Mesoblast (MESO) has a market capitalization of $1.60B. The stock trades at 13.3× sales. Over the trailing twelve months it lost $57.50M on revenue of $120.79M and burned $42.36M of free cash flow. Revenue grew 602.3% year over year.
As of its latest reported balance sheet, it holds $47.39M in cash and securities against $127.33M of debt, a net debt position of $79.94M.
Mesoblast does not currently pay a dividend.
The share price is down 26.6% over the past year. At $12.39 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $11.89 to $21.50, below its 200-day moving average of $15.63.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Mesoblast
What is the current stock price for MESO?
As of the Oct 26, 2026 close, MESO stock trades at $12.39. The 52-week range is $11.89–$21.50, with a day range of $12.33–$12.48.
What is the P/E ratio for MESO?
The P/E ratio (Price-to-Earnings) for MESO is shown in the Key Statistics section. This valuation metric helps compare Mesoblast Limited to industry peers.
Does MESO pay dividends?
Mesoblast does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MESO?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for MESO is Hold.
What is the market cap of MESO?
As of the Oct 26, 2026 close, Mesoblast's market capitalization is $1.60B, classifying it as a small-cap company. Mesoblast operates in the Healthcare sector within the Biotechnology industry.